Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

Market Cap	10.98B
Revenue (ttm)	1.32B
Net Income (ttm)	356.52M
Shares Out	70.00M
EPS (ttm)	5.09
PE Ratio	30.79
Forward PE	26.71
Dividend	3.06 (1.94%)
Ex-Dividend Date	Mar 5, 2025

Volume	36,826
Average Volume	54,169
Open	151.20
Previous Close	157.80
Day's Range	154.60 - 157.80
52-Week Range	124.80 - 202.40
Beta	n/a
RSI	52.52
Earnings Date	Apr 27, 2025

About TADAWUL:4015

Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4015

Financial Performance

In 2024, TADAWUL:4015's revenue was 1.32 billion, an increase of 19.77% compared to the previous year's 1.10 billion. Earnings were 356.52 million, an increase of 21.93%.